Funding Opportunities
Funding Opportunities

Since 1981, AFAR has provided more than $178 million to more than 4,100 talented investigators and students. To learn more about each grant, click below or contact the AFAR grant program staff at

Small Research Grant Program for the Next Generation of Researchers in Alzheimer's Disease (R03)

This National Institute on Aging (NIA) Small Research Grant Program supports important and innovative research in areas in which more scientific investigation is needed to improve the prevention, diagnosis, treatment and care for Alzheimer's disease and related dementias (AD/ADRD).

How to Apply

It is anticipated that 12-15 awards will be granted in 2019, with two years of funding totaling $200,000. The deadline is July 3, 2018.

There are two Funding Opportunity Announcements (FOAs):
RFA-AG-19-002 gives applicants the option to propose a clinical trial.
RFA-AG-19-003 is designed for applicants proposing research that does not involve a clinical trial.


Motivated by a deep interest in improving the lives of those affected by Alzheimer’s disease, The Rosalinde and Arthur Gilbert Foundation and the American Federation for Aging Research (AFAR), launched the New Investigator Awards in Alzheimer’s Disease research program in 2007. Since then, The Rosalinde and Arthur Gilbert Foundation has invested almost $4 million to support New Investigators in the United States and Israel conducting Alzheimer’s disease research. These highly talented scientists and clinicians were selected through a rigorous review process. The Program has both helped develop their individual careers and nurtured a community of researchers who are the future of Alzheimer’s disease research – part of the next generation of investigators who are advancing the research, strategies and tools we need to tackle Alzheimer’s disease and its devastating impact on patients and their caregivers. 

In 2018, the NIA launched the Small Research Grant Program for the Next Generation of Clinical Researchers in Alzheimer's Disease which will continue to support the next generation of Alzheimer’s disease researchers. The Rosalinde and Arthur Gilbert Foundation and AFAR will continue to support and organize the Annual Meetings where we nurture and develop a collective identity and cohesiveness among the investigators. Through the annual meetings and other activities, investigators can better exchange information and network more effectively. These intimate gatherings, typically attended by current grantees and alumni, provide the investigators with access to colleagues who are working on similar scientific issues related to Alzheimer’s disease, though often in different disciplines.  The meeting is an essential component of the program, and consists of a mix of scientific and leadership development sessions, networking, and mentorship opportunities.  Alumni participation further stimulates the development of scholarship, leadership and informal mentorship to the current investigators, and strengthens the network among alumni and current investigators.